Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 101Lung Neoplasms 41Neoplasms 13Neoplasm Metastasis 11Colorectal Neoplasms 8Parkinson Disease 4, Autosomal Dominant Lewy Body 6Pancreatic Neoplasms 5Mesothelioma, Malignant 5Mesothelioma 5Carcinoma 5Meningeal Carcinomatosis 4Melanoma 4Colonic Neoplasms 4Advanced Solid Tumors 4Rectal Neoplasms 3Ovarian Neoplasms 3Lung Diseases 3Carcinoma, Bronchogenic 3Adenocarcinoma 3Uterine Cervical Neoplasms 2Thoracic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Non-squamous Non-small Cell Lung Cancer 2Non-Squamous Non-small Cell Lung Cancer 2Non-Small Cell Lung Cancer Metastatic 2Non Small Cell Lung Carcinoma NSCLC 2Neoplasms by Site 2

Interventions

Radiosurgery 31Magnetic Resonance Spectroscopy 16Temozolomide 12pembrolizumab 11Nivolumab 10Specimen Handling 8Ipilimumab 8Bevacizumab 8Radiotherapy 7Mental Status and Dementia Tests 7Memantine 7abemaciclib 5Blood Specimen Collection 5Biopsy 4trastuzumab deruxtecan 3entrectinib 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Sodium Chloride 3Saline Solution 3Receptors, Interleukin-8B 3Proton Therapy 3Dexamethasone 3Cyclophosphamide 3trametinib 2pertuzumab 2osimertinib 2fluciclovine F-18 2contrast agent BR1 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Brain Neoplasms × Pemetrexed × 90 days × Clear all
NCT05012254 2026-05-05

NIVIPI-Brain

Fundación GECP

Phase 2 Active not recruiting
71 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT07492680 2026-03-25

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Bristol-Myers Squibb

Phase 2 Not yet recruiting
260 enrolled
CNSDermatologicGastrointestinal

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡